<DOC>
	<DOCNO>NCT01155544</DOCNO>
	<brief_summary>This project focus under-researched group individual develop psychotic episode short duration ( less four week ) use substance . This include individual diagnose psychotic disorder otherwise specify ( PNOS ) substance-induced psychotic disorder ( SIP ) AND substance abuse dependence . Very little known appropriate maintenance/relapse prevention management subject . These individual diagnose primary psychosis psychotic symptom short-lived non-specific , onset substance use precedes onset psychotic symptom subject experienced sufficient psychotic symptom absence substance use . However , previous study show high risk recurrence psychotic symptom . Thus , project assess efficacy second-generation antipsychotic aripiprazole maintenance treatment subject recent psychotic episode short duration associate substance use . The investigator compare aripiprazole placebo prevent recurrence psychotic symptom decrease substance use 6-month maintenance phase .</brief_summary>
	<brief_title>Improving Outcomes Psychosis Associated With Substance Use Using Aripiprazole</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>DSMIVdefined diagnosis psychosis NOS substanceinduced psychosis assess Structured Clinical Interview Axis I DSMIV Disorders ( SCIDI/P ) ( First 1998 ) onset psychotic symptom follow onset substance use current DSMIVdefined diagnosis substance abuse dependence assess SCIDI/P duration acute psychotic episode less 4 week age 16 44 competent willing sign inform consent woman , negative urine pregnancy test agreement use medically accept method birth control become pregnant study entry maintenance phase , remission psychotic symptom define 1 ) simultaneous rating &lt; 3 ( `` mild ) follow Brief PsyÂ¬chiatric Rating ScaleAnchored version item ( BPRSA ; Woerner et al . 1988 ) : suspiciousness , unusual thought content , hallucination , conceptual disorganization ; 2 ) Clinical Global Impressions Scale ( CGI ; Guy 1976 ) Severity rating 3 ( `` mild '' ) less . DSMIV criterion schizophrenia , schizophreniform disorder , schizoaffective disorder , psychotic disorder due general medical condition , share psychotic disorder , major mood disorder ( major depression bipolar mania ) psychotic feature antipsychotic treatment six month prior enrollment serious neurological endocrine disorder medical condition treatment know affect brain medical condition require treatment medication psychotropic effect significant risk suicidal homicidal ideation behavior cognitive language limitation , factor would preclude subject provide informed consent participate study procedure history treatment resistance aripiprazole medical contraindication aripiprazole hypersensitivity aripiprazole component product .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Psychotic experience</keyword>
	<keyword>Substance abuse</keyword>
	<keyword>Substance dependence</keyword>
	<keyword>Craving</keyword>
	<keyword>Mood</keyword>
	<keyword>Substance use</keyword>
</DOC>